MedTrace Logo

Expert Consensus on the Use of Isotretinoin in Acne Vulgaris: A Delphi Study

NCT07296523 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2025-12-22

No results posted yet for this study

Summary

This study is a Delphi-based expert consensus project designed to establish evidence-informed, practical recommendations for the use of isotretinoin in acne vulgaris. Despite isotretinoin being the most effective therapy for severe and refractory acne, variations persist in its indications, dosing strategies, monitoring protocols, and safety counseling.

Conditions

  • Isotretinoin
  • Isotretinoin Adverse Reaction
  • Acne

Sponsors & Collaborators

  • Venus Research Center

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-25
Primary Completion
2027-06-01
Completion
2027-09-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07296523 on ClinicalTrials.gov